Citigroup Issues Positive Forecast for Sotera Health (NASDAQ:SHC) Stock Price

Sotera Health (NASDAQ:SHC) had its price target upped by analysts at Citigroup from $18.00 to $20.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Citigroup’s target price points to a potential upside of 25.79% from the company’s previous close.

Several other research analysts also recently commented on SHC. Royal Bank of Canada reissued an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Tuesday, August 6th. Barclays increased their price objective on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research note on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Sotera Health presently has an average rating of “Moderate Buy” and a consensus target price of $16.50.

Sotera Health Price Performance

Shares of NASDAQ:SHC traded up $0.48 during midday trading on Wednesday, reaching $15.90. 702,921 shares of the company’s stock traded hands, compared to its average volume of 1,303,609. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The company has a market cap of $4.50 billion, a P/E ratio of 113.57 and a beta of 2.08. The company has a debt-to-equity ratio of 5.46, a quick ratio of 2.59 and a current ratio of 2.93. The company has a fifty day simple moving average of $15.94 and a two-hundred day simple moving average of $13.67.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The firm had revenue of $285.47 million during the quarter, compared to analyst estimates of $278.64 million. During the same period in the prior year, the company posted $0.18 earnings per share. The firm’s revenue for the quarter was up 8.5% compared to the same quarter last year. Equities analysts predict that Sotera Health will post 0.64 EPS for the current fiscal year.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $15.03, for a total value of $150,300,000.00. Following the completion of the sale, the director now directly owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 55.12% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

A number of hedge funds have recently modified their holdings of SHC. State of Alaska Department of Revenue grew its holdings in shares of Sotera Health by 20.6% during the 1st quarter. State of Alaska Department of Revenue now owns 13,490 shares of the company’s stock worth $162,000 after purchasing an additional 2,300 shares during the period. Mutual of America Capital Management LLC grew its holdings in shares of Sotera Health by 21.2% during the 1st quarter. Mutual of America Capital Management LLC now owns 74,086 shares of the company’s stock worth $890,000 after purchasing an additional 12,939 shares during the period. Texas Permanent School Fund Corp grew its holdings in shares of Sotera Health by 28.5% during the 1st quarter. Texas Permanent School Fund Corp now owns 108,545 shares of the company’s stock worth $1,304,000 after purchasing an additional 24,047 shares during the period. Duality Advisers LP grew its holdings in shares of Sotera Health by 74.9% during the 1st quarter. Duality Advisers LP now owns 29,019 shares of the company’s stock worth $349,000 after purchasing an additional 12,430 shares during the period. Finally, Swiss National Bank grew its holdings in shares of Sotera Health by 0.5% during the 1st quarter. Swiss National Bank now owns 195,900 shares of the company’s stock worth $2,353,000 after purchasing an additional 1,000 shares during the period. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.